Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
6.20
-0.09 (-1.43%)
At close: Apr 28, 2026, 4:00 PM EDT
6.16
-0.04 (-0.65%)
Pre-market: Apr 29, 2026, 4:00 AM EDT
Candel Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | - | - | - | 0.13 | 0.13 | |
| Cost of Revenue | - | - | - | 20.35 | 14.59 | |
| Gross Profit | - | - | - | -20.22 | -14.47 | |
| Selling, General & Admin | 18.42 | 14.6 | 14.41 | 14.5 | 11.26 | |
| Research & Development | 29.76 | 18.73 | 23.59 | - | - | |
| Operating Expenses | 48.18 | 33.33 | 38 | 14.5 | 11.26 | |
| Operating Income | -48.18 | -33.33 | -38 | -34.72 | -25.73 | |
| Interest Expense | -2.12 | -2.09 | -2.6 | -1.71 | -0.05 | |
| Interest & Investment Income | 3.92 | 1.09 | 2.08 | 1.22 | - | |
| Other Non Operating Income (Expenses) | 8.29 | -20.8 | 0.97 | 16.42 | -10.81 | |
| EBT Excluding Unusual Items | -38.09 | -55.14 | -37.55 | -18.79 | -36.59 | |
| Asset Writedown | -0.09 | -0.04 | -0.39 | - | - | |
| Other Unusual Items | - | - | - | - | 0.46 | |
| Pretax Income | -38.18 | -55.18 | -37.94 | -18.79 | -36.12 | |
| Net Income | -38.18 | -55.18 | -37.94 | -18.79 | -36.12 | |
| Net Income to Common | -38.18 | -55.18 | -37.94 | -18.79 | -36.12 | |
| Shares Outstanding (Basic) | 53 | 32 | 29 | 29 | 19 | |
| Shares Outstanding (Diluted) | 53 | 32 | 29 | 29 | 19 | |
| Shares Change (YoY) | 67.19% | 9.47% | 0.39% | 52.72% | 62.49% | |
| EPS (Basic) | -0.72 | -1.74 | -1.31 | -0.65 | -1.91 | |
| EPS (Diluted) | -0.72 | -1.74 | -1.31 | -0.65 | -1.91 | |
| Free Cash Flow | -38.9 | -27.04 | -34.7 | -32.72 | -24.05 | |
| Free Cash Flow Per Share | -0.73 | -0.85 | -1.20 | -1.14 | -1.27 | |
| Operating Margin | - | - | - | -27777.60% | -20580.80% | |
| Profit Margin | - | - | - | -15035.20% | -28899.20% | |
| Free Cash Flow Margin | - | - | - | -26172.80% | -19242.40% | |
| EBITDA | -47.33 | -32.34 | -37.04 | -33.94 | -25.49 | |
| D&A For EBITDA | 0.85 | 0.99 | 0.96 | 0.78 | 0.23 | |
| EBIT | -48.18 | -33.33 | -38 | -34.72 | -25.73 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.